Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level903 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,629 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00075686 | S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer | completed | Phase 3 | 766 | SWOG Cancer Research NetworkNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT00561990 | Nimotuzumab in Adults With Pancreatic Cancer | completed | Phase 2 / Phase 3 | 188 | Oncoscience AGINDUSTRY | 1 | Oct 15, 2015 | clinicaltrials |
| NCT00031837 |
| Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer |
| terminated |
| Phase 3 |
| 400 |
| Gary MorrowOTHER |
| 1 |
| Oct 14, 2015 |
| clinicaltrials |
| NCT01598584 | Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT01419002 | Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer(Net-Pac) | terminated | Phase 3 | 5 | CHIR-NetNETWORK | 1 | Jul 29, 2015 | clinicaltrials |
| NCT02510066 | Efficacy and Mechanisms of Acupuncture for Patients With Advanced Pancreatic Cancer Pain | unknown | Phase 3 | 62 | Shanghai Cancer Hospital, ChinaOTHER | 1 | Jul 28, 2015 | clinicaltrials |
| NCT01521702 | NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer(NEOPAC) | completed | Phase 3 | 2 | Institut Paoli-CalmettesOTHER | 1 | Mar 20, 2015 | clinicaltrials |
| NCT02355119 | Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer(GIP-2) | unknown | Phase 3 | 310 | Azienda Ospedaliero, Universitaria PisanaOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT00785421 | Chemotherapy With or Without Enoxaparin in Pancreatic Cancer(PROSPECT) | completed | Phase 2 / Phase 3 | 312 | CONKO-StudiengruppeOTHER | 1 | Jan 8, 2015 | clinicaltrials |
| NCT02311439 | Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas | unknown | Phase 2 / Phase 3 | 1 | Assiut UniversityOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT01586611 | A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer(Panc001) | unknown | Phase 3 | 175 | AHS Cancer Control AlbertaOTHER | 1 | Oct 2, 2014 | clinicaltrials |
| NCT01362582 | Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer(PANUSCO) | terminated | Phase 3 | 32 | National Center for Tumor Diseases, HeidelbergOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT01214720 | A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer | completed | Phase 3 | 607 | Hoffmann-La RocheINDUSTRY | 21 | Aug 13, 2014 | clinicaltrials |
| NCT00679913 | Standardization of Surgery on the Pancreatic Cancer | completed | Phase 3 | 244 | Seoul National University HospitalOTHER | 1 | Jun 6, 2014 | clinicaltrials |
| NCT02118077 | Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer(PC6) | completed | Phase 3 | 154 | Cancer Advances Inc.INDUSTRY | 0 | Apr 21, 2014 | clinicaltrials |
| NCT00044031 | Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma | completed | Phase 3 | 394 | Cancer Advances Inc.INDUSTRY | 0 | Apr 17, 2014 | clinicaltrials |
| NCT00303758 | Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 202 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Mar 4, 2014 | clinicaltrials |
| NCT01065870 | Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) | unknown | Phase 2 / Phase 3 | 64 | Columbia UniversityOTHER | 1 | Jan 29, 2014 | clinicaltrials |
| NCT00058201 | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | completed | Phase 3 | 1,030 | Royal Liverpool University HospitalOTHER_GOV | 13 | Dec 18, 2013 | clinicaltrials |
| NCT00005869 | Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005870 | Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005871 | Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003216 | Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | completed | Phase 3 | 518 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 19, 2013 | clinicaltrials |
| NCT01931449 | Evaluation of A New Digestive Reconstruction Procedure Following Pancreatoduodenectomy | unknown | Phase 3 | 200 | Southwest Hospital, ChinaOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT00425360 | Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | 1,110 | Royal Liverpool University HospitalOTHER_GOV | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00032175 | Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | 508 | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00088894 | Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | 590 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00662688 | Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer(PAM07) | terminated | Phase 3 | 42 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00033735 | Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer | completed | Phase 3 | 158 | Eisai Inc.INDUSTRY | 1 | Dec 24, 2012 | clinicaltrials |
| NCT00387348 | Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer | terminated | Phase 3 | 24 | Massachusetts General HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT00498225 | Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer(GEST) | completed | Phase 3 | 834 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 2 | Nov 2, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT00064207 | Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer | completed | Phase 2 / Phase 3 | 97 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00440167 | Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine | unknown | Phase 3 | 280 | PD Dr. med. Volker HeinemannOTHER | 0 | Jul 9, 2012 | clinicaltrials |
| NCT00003029 | Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | completed | Phase 3 | 200 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 2, 2012 | clinicaltrials |
| NCT00024427 | Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer | completed | Phase 3 | 250 | Wellstat TherapeuticsINDUSTRY | 2 | Jun 28, 2012 | clinicaltrials |
| NCT00023972 | Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | — | Daiichi SankyoINDUSTRY | 3 | May 16, 2012 | clinicaltrials |
| NCT00051467 | A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer | completed | Phase 3 | — | GenVecINDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00960284 | Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer(PACT-7) | completed | Phase 2 / Phase 3 | 102 | IRCCS San RaffaeleOTHER | 1 | Jan 13, 2012 | clinicaltrials |
| NCT00058149 | Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 2 | Sep 21, 2011 | clinicaltrials |
| NCT01330823 | L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)(CARPAN) | suspended | Phase 3 | 72 | University Medicine GreifswaldOTHER | 1 | Apr 7, 2011 | clinicaltrials |
| NCT00192712 | Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer | completed | Phase 2 / Phase 3 | 20 | Rambam Health Care CampusOTHER | 1 | Nov 10, 2010 | clinicaltrials |
| NCT00428597 | A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors | terminated | Phase 3 | 171 | PfizerINDUSTRY | 11 | Oct 11, 2010 | clinicaltrials |
| NCT00014651 | Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection | terminated | Phase 3 | — | Mayo ClinicOTHER | 1 | Aug 10, 2010 | clinicaltrials |
| NCT00541021 | Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | unknown | Phase 3 | 104 | Institut Paoli-CalmettesOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00099294 | Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer | completed | Phase 3 | 300 | Threshold PharmaceuticalsINDUSTRY | 11 | Apr 30, 2009 | clinicaltrials |
| NCT00813696 | Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer(GIP-1) | unknown | Phase 3 | 400 | Istituti Tumori Giovanni Paolo IINETWORK | 1 | Dec 23, 2008 | clinicaltrials |
| NCT00809081 | Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy | unknown | Phase 3 | 38 | Yonsei UniversityOTHER | 1 | Dec 16, 2008 | clinicaltrials |
| NCT00075452 | Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma | unknown | Phase 3 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00268411 | Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer | unknown | Phase 3 | 80 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | May 27, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Nov 17, 2015source: clinicaltrials